The epidermal growth factor receptor (EGFR) mutation exists in approximately 50% of
patients with lung adenocarcinoma and is crucial for predicting response to targeted …

Objective In this study, we aim to establish a non-invasive tool to predict epidermal growth
factor receptor (EGFR) mutation status and subtypes based on radiomic features of …

Background: The role of Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte
ratio (PLR) as an easy and inexpensive prognostic examination modality has different …

The use of targeted therapy against epidermal growth factor receptors, a tyrosine kinase
receptor, has come to the forefront for many cancers including lung cancer, head and neck …

EGFR-TKI Sensitizing Mutation Rate in Adenocarcinoma of Lung Page 1 EGFR-TKI Sensitizing
Mutation Rate Pak Armed Forces Med J 2023; 73(Suppl-1): S270 EGFR-TKI Sensitizing …

Metastasis tulang adalah salah satu komplikasi dari kanker stage lanjut. Tulang merupakan
metastasis yang paling sering dan paling awal dari kanker paru. Metastasis tulang …

Обоснование. Ингибиторы тирозинкиназы (ИТК) являются стандартом лечения EGFR-
положительного метастатического немелкоклеточного рака легкого (мНМРЛ). Разные …

Human placental-derived mesenchymal stem cells (hPMSCs) are a promising candidate to
inhibit the proliferation of hepatocellular carcinoma (HCC) cell lines such as HepG2. The …

Advances in diagnosis and treatment have enabled a targeted therapy approach to inhibit
tumor progression and provide a favorable prognosis. One of the targeted therapies in non …

Molecular biomarker testing is the standard of care for non–small cell lung cancer (NSCLC)
patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean …